Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

Ascorbic acid represents an appealing option for clinicians to utilize in the context of the global COVID-19 pandemic due to its proposed clinical efficacy, relative safety, and low cost. The aim of this study was to evaluate the efficacy and safety of using ascorbic acid in supplemental doses as ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Aljuhani, Ohoud, Saleh, Khalid Bin, Badreldin, Hisham A., Al Harthi, Abdullah, Alenazi, Mohammed, Alharbi, Aisha, Algarni, Rahmah, Al Harbi, Shmeylan, Alhammad, Abdullah M., Vishwakarma, Ramesh, Aldekhyl, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417267/
https://www.ncbi.nlm.nih.gov/pubmed/34480041
http://dx.doi.org/10.1038/s41598-021-96703-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417267/
https://www.ncbi.nlm.nih.gov/pubmed/34480041
http://dx.doi.org/10.1038/s41598-021-96703-y

Ejemplares similares